MedPath

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Not Applicable
Recruiting
Conditions
Diabetes Mellitus Type 2
Registration Number
NCT06936670
Lead Sponsor
Seattle Children's Hospital
Brief Summary

High-resistance, short-duration inspiratory muscle strength training (IMST) is a novel lifestyle intervention involving 30 inhalations against a resistive load which requires only \~5 min/day and is thus ideal for youth with T2D (Y-T2D). Investigators seek to 1: assess changes in casual and 24-hr SBP, endothelial function, and arterial stiffness after 3 months of IMST vs. sham training in Y-T2D, 2: Define changes in eGFR andalbuminuria after 3 months of IMST vs. sham in Y-T2D, 3: Interrogate mechanisms of IMST by translational assessments of NO bioavailability, endothelial NO synthase (eNOS) activation, and ROS/oxidative stress, and determine the role of circulating factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria

Aged 14-40, have had T2D for a least one year, HbA1C less than 12%.

Exclusion Criteria

Have had type II diabetes for more than 18 years, estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m2 or Albumin-to-creatinine ratio (ACR) greater than 2200mg/g, blood pressure greater than 160/100 mm Hg.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Systolic Blood Pressure3 months

Measures of casual clinic and 24-hour ambulatory blood pressure monitoring

Secondary Outcome Measures
NameTimeMethod
Endothelial function3 months

Measured by brachial artery flow-mediated dilation and endothelial cell collection and analysis.

Arterial stiffness3 months

Measured by carotid-femoral pulse-wave velocity and carotid-radial pulse-wave analysis using a SphygmoCor.

Kidney Function3 months

Measured by estimated glomerular filtration rate and albuminuria assessments

Body Composition3 months

Measured by BIS (Bioimpedance spectroscopy)

Trial Locations

Locations (2)

Seattle Children's Hospital

🇺🇸

Seattle, Washington, United States

University of Washington Medicine Diabetes Institute

🇺🇸

Seattle, Washington, United States

Seattle Children's Hospital
🇺🇸Seattle, Washington, United States
Kalie Tommerdahl
Contact
206-616-9015
ktomme@uw.edu
Kalie Tommerdahl, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.